New approach for the evaluation of antimycobacterial drug combinations in vitro (the laboratory model man).
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000995:Antitubercular Agents / Q000494:pharmacology*; D003523:Cycloserine / Q000494:pharmacology; D004357:Drug Synergism; D004917:Erythromycin / Q000494:pharmacology; D005000:Ethionamide / Q000494:pharmacology; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D008709:Methenamine / Q000494:pharmacology; D008954:Models, Biological; D009161:Mycobacterium / Q000187:drug effects*; D010068:Oxacillin / Q000494:pharmacology; D010403:Penicillin Resistance; D012293:Rifampin / Q000494:pharmacology